You are here: Home » News-CM » Companies » News
Business Standard

Zydus Cadila receives final approval for Memantine Hydrochloride Tablets

Capital Market 

From USFDA

Zydus Cadila has received final approval from USFDA to market Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. The drug is used in the treatment of moderate to severe dementia of Alzheimer's type and will be produced at the group's formulations manufacturing facility at Moraiya in Ahmedabad.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, July 12 2017. 11:11 IST
RECOMMENDED FOR YOU